BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32897650)

  • 1. Cytomorphologic features of thyroid disease in patients with DICER1 mutations: A report of cytology-histopathology correlation in 7 patients.
    Darbinyan A; Morotti R; Cai G; Prasad ML; Christison-Lagay E; Dinauer C; Adeniran AJ
    Cancer Cytopathol; 2020 Oct; 128(10):746-756. PubMed ID: 32897650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrofollicular Variant of Follicular Thyroid Carcinoma (MV-FTC) with a Somatic DICER1 Gene Mutation: Case Report and Review of the Literature.
    Hellgren LS; Hysek M; Jatta K; Zedenius J; Juhlin CC
    Head Neck Pathol; 2021 Jun; 15(2):668-675. PubMed ID: 32712880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1 Mutations Do Not Always Indicate Dismal Prognosis in Pediatric Poorly Differentiated Thyroid Carcinomas.
    Yegen G; Altay AY; Yılmaz İ; İşcan Y; Sormaz İC; Aksakal N; Önder S; Mete Ö
    Endocr Pathol; 2023 Sep; 34(3):279-286. PubMed ID: 37574466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
    Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
    Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP; Singhal R; Nikiforova MN; Yip L; Schoedel KE; Coyne C; McCoy KL; LeBeau SO; Hodak SP; Carty SE; Nikiforov YE
    Cancer Cytopathol; 2013 Apr; 121(4):197-205. PubMed ID: 22887810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An institutional experience with DICER1 mutated thyroid nodules-evaluating the cytomorphology and molecular phenotype.
    Lee SH; Vadlamudi C; Zhao Q; Yilmaz O; Cerda S
    J Am Soc Cytopathol; 2022; 11(6):335-344. PubMed ID: 35934646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.
    Khan NE; Bauer AJ; Schultz KAP; Doros L; Decastro RM; Ling A; Lodish MB; Harney LA; Kase RG; Carr AG; Rossi CT; Field A; Harris AK; Williams GM; Dehner LP; Messinger YH; Hill DA; Stewart DR
    J Clin Endocrinol Metab; 2017 May; 102(5):1614-1622. PubMed ID: 28323992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings of the North American Society of Head and Neck Pathology, Los Angeles, CA, March 20, 2022: DICER1-Related Thyroid Tumors.
    Sauer M; Barletta JA
    Head Neck Pathol; 2022 Mar; 16(1):190-199. PubMed ID: 35307774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the spectrum of thyroid carcinoma with somatic DICER1 mutation: a survey of 829 thyroid carcinomas using MSK-IMPACT next-generation sequencing platform.
    Ghossein CA; Dogan S; Farhat N; Landa I; Xu B
    Virchows Arch; 2022 Feb; 480(2):293-302. PubMed ID: 34580763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrofollicular variant follicular thyroid tumors are DICER1 mutated and exhibit distinct histological features.
    Juhlin CC; Stenman A; Zedenius J
    Histopathology; 2021 Oct; 79(4):661-666. PubMed ID: 34008223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Zhao L; Dias-Santagata D; Sadow PM; Faquin WC
    Cancer Cytopathol; 2017 May; 125(5):323-331. PubMed ID: 28192645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.
    Eszlinger M; Böhme K; Ullmann M; Görke F; Siebolts U; Neumann A; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Ruschenburg I; Paschke R
    Thyroid; 2017 Mar; 27(3):402-411. PubMed ID: 28071986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.
    Radkay LA; Chiosea SI; Seethala RR; Hodak SP; LeBeau SO; Yip L; McCoy KL; Carty SE; Schoedel KE; Nikiforova MN; Nikiforov YE; Ohori NP
    Cancer Cytopathol; 2014 Dec; 122(12):873-82. PubMed ID: 25132659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Brandler TC; Zhou F; Liu CZ; Cho M; Lau RP; Simsir A; Patel KN; Sun W
    Cancer Cytopathol; 2017 Jun; 125(6):378-388. PubMed ID: 28296267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.
    Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK
    Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DICER1 Mutations Occur in More Than One-Third of Follicular-Patterned Pediatric Papillary Thyroid Carcinomas and Correlate with a Low-Risk Disease and Female Gender Predilection.
    Onder S; Mete O; Yilmaz I; Bayram A; Bagbudar S; Altay AY; Issin G; Terzi NK; Iscan Y; Sormaz IC; Tunca F; Senyurek YG; Yegen G
    Endocr Pathol; 2022 Dec; 33(4):437-445. PubMed ID: 36251117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroblastoma: A DICER1-associated embryonal neoplasm and fine needle aspiration diagnostic criteria.
    Jitpasutham T; Faquin WC; Torous VF; Nosé V
    Diagn Cytopathol; 2023 May; 51(5):E142-E148. PubMed ID: 36688366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine-needle aspiration of the macrofollicular and microfollicular subtypes of the follicular variant of papillary carcinoma of the thyroid.
    Mesonero CE; Jugle JE; Wilbur DC; Nayar R
    Cancer; 1998 Aug; 84(4):235-44. PubMed ID: 9723599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.